Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mupirocin for S. aureus Colonization in NICU Infants
NCT02967432Phase 2Completed
- Sponsor
- Crouse Hospital
- Start
- Oct 2016
- Primary completion
- Dec 2019
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Staphylococcus aureus colonization comparing Mupirocin with Placebo (2 arms). Primary endpoint: Number of MSSA/MRSA patient colonization days. Started Oct 2016; status: completed.
02
Drugs
mupirocin
03
Conditions
Staphylococcus aureus colonization
Beyond the preview
Go deeper on NCT02967432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02967432.